COLLESE MCKEE: Open Payments
NPI 1730810078 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 50 payments from 19 companies in 2025. Trend: 2023 $166 · 2024 $410 · 2025 $949
Food & beverage: $930Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $210 |
| PFIZER INC. | 7 | $113 |
| Novo Nordisk Inc | 6 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| Insulet Corporation | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Lundbeck LLC | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: VRAYLAR, Wegovy, Kerendia, NURTEC ODT, Omnipod, JARDIANCE, CAPLYTA, FANAPT.
Industry payments across IN — which companies pay providers there.
